Clinically proven, human milk-based nutrition

More than 100,000 premature infants throughout the world have experienced proven clinical benefits from Prolacta’s 100% human milk-based nutritional products.¹

Improve health outcomes²^,³^,⁴^,⁵^,⁶ for preterm infants including:

Bronchopulmonary dysplasia (BPD)⁵^,⁷^, ⁸
Late-onset sepsis⁵^,⁶ and evaluations⁸^,
Retinopathy of prematurity (ROP)⁵^,⁷^, ⁸
Necrotising enterocolitis (NEC)²^,⁵^,⁷^,

Improve health outcomes for infants with gastroschisis

In a case series of term infants recovering from gastroschisis repair, those who received Surgifort showed (or demonstrated):

Reduced the time to full feeds⁹
Improved weight gain velocity⁹

When used as part of an exclusive human milk diet (EHMD) for preterm infants as compared to cow milk–based products, Prolacta’s products have been shown in clinical studies to:

Achieve adequate growth¹⁰^,¹¹^,¹²
Reduce feeding intolerance⁷
Lower incidence of mortality and morbidity³^,⁴^,⁵
Shorten neonatal intensive care unit (NICU) stays⁷
Reduce hospital costs⁷^,¹³

Clinical evidence

Premature infant nutrition

Fortifier

Supplementing mother’s own milk (MOM) with the first commercially available human milk-based fortifier, made from 100% human donor milk instead of cow milk

Caloric fortifier

When premature infants need additional calories to support their growth, this human milk-based caloric fortifier delivers

Ready-to-feed

This ready-to-feed, human milk-based product offers NICUs an alternative to cow’s milk-based formula when mother’s own milk is not available

Human donor milk

When an adequate supply of MOM is not available, donor milk is rapidly becoming the standard of care for feeding premature infants

Term infant nutrition

Fortifier

Term babies with gastroschisis have special nutritional needs considering their delicate gastrointestinal system. When recovering from surgery, these term babies need human milk and may need human-milk based fortifiers for additional nutrition to help recover from surgery.

Adequately nourishing infants with mother’s own milk (MOM) fortified with human milk-based products

Since 2012, the American Academy of Pediatrics (AAP) has recommended human milk for preterm infants, whether MOM or pasteurised donor human milk if MOM is unavailable.¹⁴ For those infants born weighing less than 1500 g, the AAP recommends fortifying MOM or donor human milk, with protein and minerals, to ensure optimal nutrient intake. ¹⁵

In 2025, the US Food and Drug Administration approved the first human milk-based fortifier for term infants recovering from surgery for gastroschisis.

Our products help hospitals meet the nutritional needs of their medically fragile patients.

Made with lab-tested donor milk in U.S. FDA-regulated manufacturing facilities

Hospitals choose Prolacta’s 100% human milk-based nutritional products for the assurance that they are receiving safe, standardised donor milk formulations processed in a pharmaceutical-grade facility under the strictest quality and safety guidelines to protect the health and wellbeing of their most fragile patients¹.

Our process

A cost-effective solution

When used as part of an EHMD, our human milk-based nutritional products are clinically shown to increase survival and reduce the overall cost of care, compared to cow milk–based fortifier or preterm formula, in extremely premature infants. ⁷^, ¹²

Products